hit counter
USA Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 201 - 220 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Viridian Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Viridian Therapeutics, Inc.

Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Achieve Life Sciences, Inc.

Replimune to Present at the Virtual SVB Securities Global Biopharma Conference

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Replimune Inc.

Immix Biopharma Announces Dosing of First 2 Patients in its IMX-110 + BeiGene/Novartis anti-PD-1 Tislelizumab Phase 1b/2a Combination Clinical Trial in Patients with Advanced Cancer

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Immix Biopharma, Inc.

Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Praxis Precision Medicines, Inc.

BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  BioSig Technologies, Inc.

Keros Therapeutics to Present at the SVB Securities Global Biopharma Conference

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Keros Therapeutics, Inc.

RAPT Therapeutics to Participate in the SVB Securities Global Biopharma Conference

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  RAPT Therapeutics, Inc.

Selecta Biosciences to Participate at the SVB Securities Global Biopharma Conference

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Selecta Biosciences, Inc.

Onconova Therapeutics Announces Additional Clinical Data Demonstrating Rigosertib’s Monotherapy Activity in RDEB-Associated Squamous Cell Carcinoma

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Onconova Therapeutics, Inc.

Pliant Therapeutics to Participate in Upcoming Investor Events

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Pliant Therapeutics, Inc.

Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 Total Revenues and Provides Full Year 2023 Revenue Guidance

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Catalyst Pharmaceuticals, Inc.

Outlook Therapeutics® to Present at the SVB Securities Global Biopharma Conference

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Outlook Therapeutics, Inc.

Nearly Three Out of Four Colorado Smokers Want to Quit and Now Have a New Option That “Helps You Smoke Less”  

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  22nd Century Group, Inc.

Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Cytek Biosciences Inc.

Elektrofi Announces Collaboration with Thermo Fisher Scientific to Strengthen Manufacturing Capabilities for Future Clinical Trials

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Elektrofi

Silk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Silk Road Medical,Inc.

Osteal Therapeutics Announces First Subject Enrollment in Second Phase 2 Clinical Trial of VT-X7 Combination Product for Treatment of Periprosthetic Joint Infection

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Osteal Therapeutics

HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  HeartSciences Inc.

LIXTE BIOTECHNOLOGY HOLDINGS, INC. REPORTS THAT ITS LEAD CLINICAL COMPOUND, LB-100, CAN KILL CANCER CELLS THROUGH HYPER-STIMULATION OF CELL PROLIFERATION SIGNALS IN PRE-CLINICAL MODELS

Read more ››
By: GlobenewsWire - 07 Feb 2023
Related companies:  Lixte Biotechnology Holdings, Inc
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Looking for companies outside of the United States?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • February 2023
    • Biotechgate Digital Partnering February 2023
    • Dusseldorf: 7th ECP - The first industry speed dating event
  • March 2023
    • Zurich: 16th​ Annual European Life Sciences CEO Forum
See Events »
Add an Event »

Latest company news

MediciNova Announces Health Canada Grants Authorization to Commence Multi-arm Phase 2/3 Clinical Trial to Evaluate MN-166 (ibudilast) in Long COVID
09 Feb 2023 (GlobenewsWire)

EYLEA® (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA
09 Feb 2023 (GlobenewsWire)

Carrier screening market size to grow by USD 2.36 billion from 2021 to 2026: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio
09 Feb 2023 (PR Newswire Association LLC.)

Biotechgate database

About Biotechgate
The USA Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com